EUVIMEDExplore EUVIMED
Crossref

C / EBPβ isoform‐specific regulation of podocyte pyroptosis in lupus nephritis‐induced renal injury

Huimei Zou iD, Min Chen, Xiuhong Wang, Jie Yu, Xiaoying Li, Ying Xie, Jun Liu, Miao Liu, Lifen Xu, Qiong Zhang, Xiaoxue Tian, Fan Zhang iD and 1 more

The Journal of Pathology · 2023-11 · 261 (3) · 269-285

DOI: 10.1002/path.6174 ↗

At a glance

Journal article in The Journal of Pathology, published online on 2023-08-21. Written by Huimei Zou and 12 co-authors. Institution: Department of Pathophysiology, Guizhou Medical University, Guiyang, PR China. Major MEDLINE topics: Podocytes, Lupus Nephritis, CCAAT-Enhancer-Binding Protein-beta, Pyroptosis. Cited 25 times so far (Crossref); 52 references. Funded by: National Natural Science Foundation of China, Natural Science Foundation of Guizhou Province, Postgraduate Research Foundation of Guizhou Education Department.

AbstractSubjectsBibliographic detailsCiteRelated studies

Abstract (original language)

As an essential factor in the prognosis of systemic lupus erythematosus (SLE), lupus nephritis (LN) can accelerate the rate at which patients with SLE can transition to chronic kidney disease or even end‐stage renal disease. Podocytes now appear to be a possible direct target in LN in addition to being prone to collateral damage from glomerular capillary lesions induces by immune complexes and inflammatory processes. The NLRP3 inflammasome is regulated by CCAAT/enhancer‐binding protein β (C/EBPβ), which is involved in the pathogenesis of SLE. However, the role and mechanism of C/EBPβ in LN remain unclear. In this investigation, glomerular podocytes treated with LN serum and MRL/lpr mice were employed as in vivo and in vitro models of LN, respectively. In vivo , the expression of C/EBPβ isoforms was detected in kidney specimens of humans and mice with LN. Then we assessed the effect of C/EBPβ inhibition on renal structure and function by injecting RNAi adeno‐associated virus of C/EBPβ shRNA into MRL/lpr mice. In vitro , glomerular podocytes were treated with LN serum and C/EBPβ siRNA to explore the role of C/EBPβ in the activation of the AIM2 inflammasome and podocyte injury. C/EBPβ‐LAP and C/EBPβ‐LIP were significantly overexpressed in kidney tissue samples from LN patients and mice, and C/EBPβ inhibition significantly alleviated renal function damage and ameliorated renal structural deficiencies. Inflammatory pathways downstream from the AIM2 inflammasome could be suppressed by C/EBPβ knockdown. Furthermore, the upregulation of C/EBPβ‐LAP could activate the AIM2 inflammasome and podocyte pyroptosis by binding to the promoters of AIM2 and CASPASE1 to enhance their expression, and the knockdown of AIM2 or (and) caspase‐1 reversed the effects of C/EBPβ‐LAP overexpression. Interestingly, C/EBPβ‐LIP overexpression could transcriptionally inhibit IRAG and promote Ca 2+ release‐mediated activation of the AIM2 inflammasome. This finding suggests that C/EBPβ is not only involved in the regulation of the expression of key proteins of the AIM2 inflammasome but also affects the polymerization of key proteins of the AIM2 inflammasome through the regulation of Ca 2+ release. In conclusion, this study provides a new idea for studying the regulatory mechanism of C/EBPβ and provides a theoretical basis for the early diagnosis and treatment of LN in the future. © 2023 The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

PodocytesLupus NephritisCCAAT-Enhancer-Binding Protein-betaPyroptosisAnimalsHumansMice, Inbred MRL lprInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinMiceProtein IsoformsDisease Models, AnimalFemaleCaspase 1

Author keywords

AIM2 inflammasomeC/EBPβCa2+lupus nephritispodocyte pyroptosis

Substances

CCAAT-Enhancer-Binding Protein-betaInflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinProtein IsoformsCEBPB protein, humanCebpb protein, mouseCaspase 1

Authors and institutions

  • Department of Pathophysiology, Guizhou Medical University, Guiyang, PR China.
  • Guizhou Provincial Key Laboratory of Pathogenesis and Drug Research on Common Chronic Diseases, Guizhou Medical University, Guiyang, PR China.
  • School of Nursing, Guizhou Medical University, Guiyang, PR China.
  • Key Laboratory of Endemic and Ethnic Diseases, Ministry of Education, Guizhou Medical University, Guiyang, PR China.
  • Department of Nephrology, The First People's Hospital of Guiyang, Guiyang, PR China.
  • Department of Rheumatology, Affiliated Hospital of Guizhou Medical University, Guiyang, PR China.

ORCID profiles: Huimei Zou, Fan Zhang

Funding

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guizhou Province
  • Postgraduate Research Foundation of Guizhou Education Department

Cite

APA

Zou, H., Chen, M., Wang, X., Yu, J., Li, X., Xie, Y., Liu, J., Liu, M., Xu, L., Zhang, Q., Tian, X., Zhang, F., & Guo, B. (2023). C / EBPβ isoform‐specific regulation of podocyte pyroptosis in lupus nephritis‐induced renal injury. The Journal of Pathology, 261(3), 269-285. https://doi.org/10.1002/path.6174

Vancouver

Zou H, Chen M, Wang X, Yu J, Li X, Xie Y, et al. C / EBPβ isoform‐specific regulation of podocyte pyroptosis in lupus nephritis‐induced renal injury. The Journal of Pathology. 2023;261(3):269-285. doi:10.1002/path.6174

BibTeX
@article{Zou2023,
  author = {Zou, Huimei and Chen, Min and Wang, Xiuhong and Yu, Jie and Li, Xiaoying and Xie, Ying and Liu, Jun and Liu, Miao and Xu, Lifen and Zhang, Qiong and Tian, Xiaoxue and Zhang, Fan and Guo, Bing},
  title = {C / EBPβ isoform‐specific regulation of podocyte pyroptosis in lupus nephritis‐induced renal injury},
  journal = {The Journal of Pathology},
  year = {2023},
  volume = {261},
  number = {3},
  pages = {269--285},
  doi = {10.1002/path.6174}
}
Start for free →